By Product
By Scale
By End-Use
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Rest of Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Single-use Upstream Bioprocessing Market Snapshot
Chapter 4. Global Single-use Upstream Bioprocessing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Product & Market Share, 2020 & 2030
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Product:
5.2.1. Single-use Bioreactors
5.2.2. Single-use Mixers
5.2.3. Single-use Media Bags
5.2.4. Single-use Filters
5.2.5. Single-use Sampling Systems
5.2.6. Single-use Connectors
5.2.7. Others
Chapter 6. Market Segmentation 2: By Scale Estimates & Trend Analysis
6.1. By Scale & Market Share, 2020 & 2030
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Scale:
6.2.1. Preclinical / Clinical
6.2.2. Commercial
Chapter 7. Market Segmentation 3: By End-Use Estimates & Trend Analysis
7.1. By End-Use & Market Share, 2020 & 2030
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By End-Use:
7.2.1. Biopharmaceutical Manufacturer
7.2.2. CMOs & CROs
Chapter 8. Single-use Upstream Bioprocessing Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Single-use Upstream Bioprocessing Market revenue (US$ Million) estimates and forecasts By Product, 2020-2030
8.1.2. North America Single-use Upstream Bioprocessing Market revenue (US$ Million) estimates and forecasts By Scale, 2020-2030
8.1.3. North America Single-use Upstream Bioprocessing Market revenue (US$ Million) estimates and forecasts by End-Use, 2020-2030
8.1.4. North America Single-use Upstream Bioprocessing Market revenue (US$ Million) estimates and forecasts by country, 2020-2030
8.2. Europe
8.2.1. Europe Single-use Upstream Bioprocessing Market revenue (US$ Million) By Product, 2020-2030
8.2.2. Europe Single-use Upstream Bioprocessing Market revenue (US$ Million) By Scale, 2020-2030
8.2.3. Europe Single-use Upstream Bioprocessing Market revenue (US$ Million) estimates and forecasts by End-Use, 2020-2030
8.2.4. Europe Single-use Upstream Bioprocessing Market revenue (US$ Million) by country, 2020-2030
8.3. Asia Pacific
8.3.1. Asia Pacific Single-use Upstream Bioprocessing Market revenue (US$ Million) By Product, 2020-2030
8.3.2. Asia Pacific Single-use Upstream Bioprocessing Market revenue (US$ Million) By Scale, 2020-2030
8.3.3. Asia Pacific Single-use Upstream Bioprocessing Market revenue (US$ Million) estimates and forecasts by End-Use, 2020-2030
8.3.4. Asia Pacific Single-use Upstream Bioprocessing Market revenue (US$ Million) by country, 2020-2030
8.4. Latin America
8.4.1. Latin America Single-use Upstream Bioprocessing Market revenue (US$ Million) By Product, (US$ Million)
8.4.2. Latin America Single-use Upstream Bioprocessing Market revenue (US$ Million) By Scale, (US$ Million)
8.4.3. Latin America Single-use Upstream Bioprocessing Market revenue (US$ Million) estimates and forecasts by End-Use, 2020-2030
8.4.4. Latin America Single-use Upstream Bioprocessing Market revenue (US$ Million) by country, 2020-2030
8.5. Middle East & Africa
8.5.1. Middle East & Africa Single-use Upstream Bioprocessing Market revenue (US$ Million) By Product, (US$ Million)
8.5.2. Middle East & Africa Single-use Upstream Bioprocessing Market revenue (US$ Million) By Scale, (US$ Million)
8.5.3. Middle East & Africa Single-use Upstream Bioprocessing Market revenue (US$ Million) estimates and forecasts by End-Use, 2020-2030
8.5.4. Middle East & Africa Single-use Upstream Bioprocessing Market revenue (US$ Million) by country, 2020-2030
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Danaher Corporation (Cytiva),
9.2.2. Sartorius AG,
9.2.3. Thermo Fisher Scientific, Inc.,
9.2.4. Merck KGaA,
9.2.5. Corning Incorporated,
9.2.6. Pall Corporation,
9.2.7. General Electric Company (GE Healthcare)
9.2.8. Eppendorf AG,
9.2.9. Rentschler Biopharma SE
9.2.10. Lonza,
9.2.11. Meissner Filtration Products, Inc.,
9.2.12. JM BioConnect,
9.2.13. Boehringer Ingelheim GmbH
9.2.14. Infors A
9.2.15. Other Prominent Players
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.